Home - Dr. Coy

News

At this year’s BIG BANG HEALTH Festival, Dr Johannes Coy was featured as a panelist on the DUP Stage. Together with Prof Dr Dietrich Grönemeyer and Prof Dr Wolfram Gössling, he spoke about the chances of early detection and treatment of pancreatic cancer in his panel talk.

To the Big Bang Health panel talk

Message of congratulations from Dr Johannes Coy to Prof. Svante Pääbo

for receiving the Nobel Prize for Medicine 2022. The palaeogenetics founded by Pääbo and the basic research of the Max Planck Society open up new options and underline the importance of TKTL1 for the diagnosis and treatment of diseases.

We will rethink medicine – TKTL1 Talk with Dr Johannes
Coy

In the 11-minutes interview, Coy talks about the importance of the

latest findings on TKTL1 for cancer therapy and perspectives on

immunotherapy.

About Dr Johannes Coy

The foundation of Dr Johannes Coy’s work

The identification of the two genes TKTL1 and DNaseX as part of the work in the genome analysis project led by Prof. Harald zur Hausen, who later won the Nobel Prize for Medicine, laid the foundation for Coy’s current involvement as a scientist, developer and entrepreneur.

Discovery of the TKTL1 gene

Thanks to the discovery and study of the TKTL1 gene, a marker for the early detection of malignant tumours is now available, as well as a target for treatment with benfo-oxythiamine.

Learn more

Discovery of the DNaseX gene

Thanks to the discovery and research of the DNaseX gene, a marker is now available that enables early detection of all types of
tumours.

Learn more

Big TKTL1 interview with Dr Johannes Coy

The big exclusive interview with Dr. Johannes Coy about the gene he discovered, TKTL1, and its importance for our lives.

Lecture by Dr Johannes Coy on “Sugar versus intelligent sugars:

at the launch event of the “BE ACCEPTED” initiative for women with cancer, supported by the European Society of Radiology (ESR) as part of ECR 2022.

Developments

Coy’s scientific discoveries are the basis for a number of developments that are already being used today for the early detection and therapy of serious diseases and whose uniqueness is underpinned by various patents.

EDIM-technology PanTum Detect Benfo-oxythiamine

EDIM technology

Epitope detection in monocytes

The development of Epitope Detection in Monocytes (EDIM), a new flow cytometry-based method for detecting biomarkers in blood, sets the stage for the future development of numerous new diagnostic tests.

Learn more

PanTum Detect

Blood test for the early detection of tumours

Using EDIM technology to detect the biomarkers DNaseX (Apo10) and TKTL1, a unique new blood test was created for the early detection of tumours.

Learn more

Benfo-oxythiamine

Inhibitor against chemoresistant cancer cells

The establishment of the vitamin B1 derivative benfo-oxythiamine (B-OT) opens up a new treatment option that resensitises resistant tumours to established cancer drugs.

Learn more

News

The foundation of Dr Johannes Coy’s work

Discovery of the TKTL1 gene

Discovery of the DNaseX gene

Developments

EDIM technology

Epitope detection in monocytes

PanTum Detect

Blood test for the early detection of tumours

Benfo-oxythiamine

Inhibitor against chemoresistant cancer cells

Menu

Legal information